Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Harold J. G. M. van Megen, MD
JCP
Original Research
Behavior Therapy Augments Response of Patients With Obsessive-Compulsive Disorder Responding to Drug Treatment
September 15, 2005
Nienke H. Tenneij
,
Harold J. G. M. van Megen
,
Damiaan A. J. P. Denys
, et al
JCP
Letter to the Editor
Efficacy of Quetiapine in Generalized Social Anxiety Disorder: Results From an Open-Label Study
April 15, 2005
Sara I. J. Schutters
,
Harold J. G. M. van Megen
,
Herman G. M. Westenberg
JCP
Original Research
A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors
August 16, 2004
Damiaan Denys
,
Femke de Geus
,
Harold J. G. M. van Megen
, et al
JCP
Original Research
A Double-Blind Switch Study of Paroxetine and Venlafaxine in Obsessive-Compulsive Disorder
January 1, 2004
Damiaan Denys
,
Harold J. G. M. van Megen
,
Nic van der Wee
, et al